Science Translational Medicine research article reporting that reducing the expression of N-glycans on tumor cells enhances the therapeutic potential of chimeric antigen receptor T cells against solid tumorsAccepted version before final editing. Find the final version at https://www.science.org/doi/10.1126/scitranslmed.abg307
Abnormal glycosylation is one of the hallmarks of the cancer cell and is associated with tumor invas...
cu ea eu the AR tients, adoptive T-cell therapy has been improved by intro- Cancer stem cells (CSCs)...
Aberrant posttranslational modifications of cellular proteins represent a broad repertoire of putati...
Tumour growth is accompanied by tumour evasion of the immune system, a process that is facilitated b...
International audienceTumor growth is accompanied with dramatic changes in the cellular glycome, suc...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
The clinical efficacy of therapies targeting the PD-1/PD-L1 pathway is still limited. In this issue ...
Contains fulltext : 215801.pdf (publisher's version ) (Open Access)Tumors that lac...
Tumors can induce the generation and accumulation of immunosuppressive cells such as myeloid-derived...
Glycosylation is an important post-translational modification, giving rise to a diverse and abundant...
T-cells play a critical role in tumor immunity. Indeed, the presence of tumor-infiltrating lymphocyt...
Therapeutic anti-glycan antibodies for cancer treatment are limited, in spite of the differential gl...
Journal Article;Attention has recently focused on new cancer immunotherapy protocols aiming to activ...
The majority of proteins are modified in post-translational events and one of the most common of the...
Abnormal glycosylation is one of the hallmarks of the cancer cell and is associated with tumor invas...
cu ea eu the AR tients, adoptive T-cell therapy has been improved by intro- Cancer stem cells (CSCs)...
Aberrant posttranslational modifications of cellular proteins represent a broad repertoire of putati...
Tumour growth is accompanied by tumour evasion of the immune system, a process that is facilitated b...
International audienceTumor growth is accompanied with dramatic changes in the cellular glycome, suc...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
The clinical efficacy of therapies targeting the PD-1/PD-L1 pathway is still limited. In this issue ...
Contains fulltext : 215801.pdf (publisher's version ) (Open Access)Tumors that lac...
Tumors can induce the generation and accumulation of immunosuppressive cells such as myeloid-derived...
Glycosylation is an important post-translational modification, giving rise to a diverse and abundant...
T-cells play a critical role in tumor immunity. Indeed, the presence of tumor-infiltrating lymphocyt...
Therapeutic anti-glycan antibodies for cancer treatment are limited, in spite of the differential gl...
Journal Article;Attention has recently focused on new cancer immunotherapy protocols aiming to activ...
The majority of proteins are modified in post-translational events and one of the most common of the...
Abnormal glycosylation is one of the hallmarks of the cancer cell and is associated with tumor invas...
cu ea eu the AR tients, adoptive T-cell therapy has been improved by intro- Cancer stem cells (CSCs)...
Aberrant posttranslational modifications of cellular proteins represent a broad repertoire of putati...